Homing defect of cultured human hematopoietic cells in the NOD/SCID mouse is mediated by Fas/CD95

Bianling Liu, Sharron M. Buckley, Ian D. Lewis, Anne I. Goldman, John E. Wagner, Johannes C.M. Van Der Loo

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Objective. To determine the bone marrow homing efficiency (20 hours) of cultured compared to noncultured umbilical cord blood (UCB)-derived human hematopoietic cells in the nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse, and to explain the difference in homing between these populations. Methods. Human UCB CD34+ cells were cultured for up to 5 days, reselected, and used for transplantation, phenotype analysis, and functional studies, including adhesion and trans-endothelial migration assays. Seeding of CD34+ cells was measured after labeling of cells with 111-Indium, while homing of colony-forming cells (CFC) and SCID-repopulating (SRC) cells was determined using functional assays. Results. Short-term culture was associated with a decrease in the 20-hour homing of CD34+ cells, CFC, and SRC to the BM. Although cultured compared to noncultured cells showed increased expression and function (adhesion/migration) of several cell adhesion molecules described to play a role in homing and engraftment, culture also induced expression of Fas/CD95 and rendered cells more susceptible to apoptosis. Finally, we demonstrate that the level of Fas/CD95 on cultured cells was inversely related to the ability of CFC to home to the BM, and that the homing of cultured CFC could be restored by incubating cells prior to transplantation with Fas/CD95-blocking mAb ZB4. Conclusion. These data implicate Fas/CD95 in the homing defect of cultured human hematopoietic cells in the NOD/SCID transplant model and suggest that prevention of apoptosis may be an important strategy to improve engraftment of ex vivo-manipulated HSC in a clinical setting.

Original languageEnglish (US)
Pages (from-to)824-832
Number of pages9
JournalExperimental Hematology
Volume31
Issue number9
DOIs
StatePublished - Sep 1 2003

Fingerprint

SCID Mice
Fetal Blood
Transplantation
Apoptosis
Indium
Cell Adhesion Molecules
Cultured Cells
Blood Cells

ASJC Scopus subject areas

  • Molecular Biology
  • Hematology
  • Genetics
  • Cell Biology
  • Cancer Research

Cite this

Homing defect of cultured human hematopoietic cells in the NOD/SCID mouse is mediated by Fas/CD95. / Liu, Bianling; Buckley, Sharron M.; Lewis, Ian D.; Goldman, Anne I.; Wagner, John E.; Van Der Loo, Johannes C.M.

In: Experimental Hematology, Vol. 31, No. 9, 01.09.2003, p. 824-832.

Research output: Contribution to journalArticle

Liu, Bianling ; Buckley, Sharron M. ; Lewis, Ian D. ; Goldman, Anne I. ; Wagner, John E. ; Van Der Loo, Johannes C.M. / Homing defect of cultured human hematopoietic cells in the NOD/SCID mouse is mediated by Fas/CD95. In: Experimental Hematology. 2003 ; Vol. 31, No. 9. pp. 824-832.
@article{0c88c7a5dbe14e71b230e93d33d5a820,
title = "Homing defect of cultured human hematopoietic cells in the NOD/SCID mouse is mediated by Fas/CD95",
abstract = "Objective. To determine the bone marrow homing efficiency (20 hours) of cultured compared to noncultured umbilical cord blood (UCB)-derived human hematopoietic cells in the nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse, and to explain the difference in homing between these populations. Methods. Human UCB CD34+ cells were cultured for up to 5 days, reselected, and used for transplantation, phenotype analysis, and functional studies, including adhesion and trans-endothelial migration assays. Seeding of CD34+ cells was measured after labeling of cells with 111-Indium, while homing of colony-forming cells (CFC) and SCID-repopulating (SRC) cells was determined using functional assays. Results. Short-term culture was associated with a decrease in the 20-hour homing of CD34+ cells, CFC, and SRC to the BM. Although cultured compared to noncultured cells showed increased expression and function (adhesion/migration) of several cell adhesion molecules described to play a role in homing and engraftment, culture also induced expression of Fas/CD95 and rendered cells more susceptible to apoptosis. Finally, we demonstrate that the level of Fas/CD95 on cultured cells was inversely related to the ability of CFC to home to the BM, and that the homing of cultured CFC could be restored by incubating cells prior to transplantation with Fas/CD95-blocking mAb ZB4. Conclusion. These data implicate Fas/CD95 in the homing defect of cultured human hematopoietic cells in the NOD/SCID transplant model and suggest that prevention of apoptosis may be an important strategy to improve engraftment of ex vivo-manipulated HSC in a clinical setting.",
author = "Bianling Liu and Buckley, {Sharron M.} and Lewis, {Ian D.} and Goldman, {Anne I.} and Wagner, {John E.} and {Van Der Loo}, {Johannes C.M.}",
year = "2003",
month = "9",
day = "1",
doi = "10.1016/S0301-472X(03)00161-9",
language = "English (US)",
volume = "31",
pages = "824--832",
journal = "Experimental Hematology",
issn = "0301-472X",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Homing defect of cultured human hematopoietic cells in the NOD/SCID mouse is mediated by Fas/CD95

AU - Liu, Bianling

AU - Buckley, Sharron M.

AU - Lewis, Ian D.

AU - Goldman, Anne I.

AU - Wagner, John E.

AU - Van Der Loo, Johannes C.M.

PY - 2003/9/1

Y1 - 2003/9/1

N2 - Objective. To determine the bone marrow homing efficiency (20 hours) of cultured compared to noncultured umbilical cord blood (UCB)-derived human hematopoietic cells in the nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse, and to explain the difference in homing between these populations. Methods. Human UCB CD34+ cells were cultured for up to 5 days, reselected, and used for transplantation, phenotype analysis, and functional studies, including adhesion and trans-endothelial migration assays. Seeding of CD34+ cells was measured after labeling of cells with 111-Indium, while homing of colony-forming cells (CFC) and SCID-repopulating (SRC) cells was determined using functional assays. Results. Short-term culture was associated with a decrease in the 20-hour homing of CD34+ cells, CFC, and SRC to the BM. Although cultured compared to noncultured cells showed increased expression and function (adhesion/migration) of several cell adhesion molecules described to play a role in homing and engraftment, culture also induced expression of Fas/CD95 and rendered cells more susceptible to apoptosis. Finally, we demonstrate that the level of Fas/CD95 on cultured cells was inversely related to the ability of CFC to home to the BM, and that the homing of cultured CFC could be restored by incubating cells prior to transplantation with Fas/CD95-blocking mAb ZB4. Conclusion. These data implicate Fas/CD95 in the homing defect of cultured human hematopoietic cells in the NOD/SCID transplant model and suggest that prevention of apoptosis may be an important strategy to improve engraftment of ex vivo-manipulated HSC in a clinical setting.

AB - Objective. To determine the bone marrow homing efficiency (20 hours) of cultured compared to noncultured umbilical cord blood (UCB)-derived human hematopoietic cells in the nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse, and to explain the difference in homing between these populations. Methods. Human UCB CD34+ cells were cultured for up to 5 days, reselected, and used for transplantation, phenotype analysis, and functional studies, including adhesion and trans-endothelial migration assays. Seeding of CD34+ cells was measured after labeling of cells with 111-Indium, while homing of colony-forming cells (CFC) and SCID-repopulating (SRC) cells was determined using functional assays. Results. Short-term culture was associated with a decrease in the 20-hour homing of CD34+ cells, CFC, and SRC to the BM. Although cultured compared to noncultured cells showed increased expression and function (adhesion/migration) of several cell adhesion molecules described to play a role in homing and engraftment, culture also induced expression of Fas/CD95 and rendered cells more susceptible to apoptosis. Finally, we demonstrate that the level of Fas/CD95 on cultured cells was inversely related to the ability of CFC to home to the BM, and that the homing of cultured CFC could be restored by incubating cells prior to transplantation with Fas/CD95-blocking mAb ZB4. Conclusion. These data implicate Fas/CD95 in the homing defect of cultured human hematopoietic cells in the NOD/SCID transplant model and suggest that prevention of apoptosis may be an important strategy to improve engraftment of ex vivo-manipulated HSC in a clinical setting.

UR - http://www.scopus.com/inward/record.url?scp=0042736863&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042736863&partnerID=8YFLogxK

U2 - 10.1016/S0301-472X(03)00161-9

DO - 10.1016/S0301-472X(03)00161-9

M3 - Article

C2 - 12962729

AN - SCOPUS:0042736863

VL - 31

SP - 824

EP - 832

JO - Experimental Hematology

JF - Experimental Hematology

SN - 0301-472X

IS - 9

ER -